BrainStorm Cell Therapeutics
BCLI
#9833
Rank
NZ$1.97 M
Marketcap
$0.37
Share price
3.51%
Change (1 day)
11.58%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.98

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.95. In 2022 the company made an earnings per share (EPS) of -$1.07 an increase over its 2021 EPS that were of -$1.10.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.98-8.39%
2022-$1.07-2.94%
2021-$1.10-37.04%
2020-$1.751.89%
2019-$1.7151.43%
2018-$1.13159.26%
2017-$0.44-3.57%
2016-$0.45-37.78%
2015-$0.73-33.82%
2014-$1.1036%
2013-$0.8111.11%
2012-$0.7350%
2011-$0.48-50%
2010-$0.97-233.33%
2009$0.73-142.86%
2008-$1.70-65%
2007-$4.85
2005$1.60-108.03%
2004-$19.9413203.07%
2003-$0.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$7.10-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.20 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.48 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.84-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.37 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA